COSMOS Pharmaceutical Corporation (CSMYF)
USD 49.22
(0.0%)
USD 49.22
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 34.06 Billion JPY | 87.15% |
| 2023 | 18.2 Billion JPY | 93.36% |
| 2022 | 9.41 Billion JPY | -9.87% |
| 2021 | 10.44 Billion JPY | -13.84% |
| 2020 | 12.12 Billion JPY | -12.64% |
| 2019 | 13.87 Billion JPY | -19.34% |
| 2018 | 17.2 Billion JPY | -21.0% |
| 2017 | 21.77 Billion JPY | -18.35% |
| 2016 | 26.66 Billion JPY | 55.69% |
| 2015 | 17.12 Billion JPY | 158.08% |
| 2014 | 6.63 Billion JPY | 81.04% |
| 2013 | 3.66 Billion JPY | -30.04% |
| 2012 | 5.24 Billion JPY | -26.37% |
| 2011 | 7.11 Billion JPY | -27.77% |
| 2010 | 9.85 Billion JPY | -2.0% |
| 2009 | 10.05 Billion JPY | 19.61% |
| 2008 | 8.4 Billion JPY | 15.96% |
| 2007 | 7.24 Billion JPY | 56.87% |
| 2006 | 4.62 Billion JPY | -30.76% |
| 2005 | 6.67 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 10.7 Billion JPY | -6.02% |
| 2024 Q4 | 34.06 Billion JPY | 218.26% |
| 2024 FY | 34.06 Billion JPY | 87.15% |
| 2024 Q2 | 11.38 Billion JPY | -5.67% |
| 2024 Q1 | 12.07 Billion JPY | -33.66% |
| 2023 Q3 | 6.32 Billion JPY | 73.31% |
| 2023 FY | 18.2 Billion JPY | 93.36% |
| 2023 Q4 | 18.2 Billion JPY | 187.81% |
| 2023 Q2 | 3.64 Billion JPY | -8.57% |
| 2023 Q1 | 3.99 Billion JPY | -57.6% |
| 2022 Q4 | 9.41 Billion JPY | 111.1% |
| 2022 Q3 | 4.45 Billion JPY | -7.7% |
| 2022 FY | 9.41 Billion JPY | -9.87% |
| 2022 Q1 | 5.2 Billion JPY | -50.19% |
| 2022 Q2 | 4.83 Billion JPY | -7.13% |
| 2021 Q4 | 10.44 Billion JPY | 75.68% |
| 2021 Q1 | 6.68 Billion JPY | -44.81% |
| 2021 Q3 | 5.94 Billion JPY | -5.89% |
| 2021 Q2 | 6.31 Billion JPY | -5.56% |
| 2021 FY | 10.44 Billion JPY | -13.84% |
| 2020 Q4 | 12.12 Billion JPY | 63.09% |
| 2020 FY | 12.12 Billion JPY | -12.64% |
| 2020 Q1 | 8.17 Billion JPY | -41.08% |
| 2020 Q2 | 7.8 Billion JPY | -4.54% |
| 2020 Q3 | 7.43 Billion JPY | -4.77% |
| 2019 Q1 | 10.62 Billion JPY | -38.23% |
| 2019 Q4 | 13.87 Billion JPY | -10.52% |
| 2019 FY | 13.87 Billion JPY | -19.34% |
| 2019 Q2 | 9.81 Billion JPY | -7.61% |
| 2019 Q3 | 15.5 Billion JPY | 57.98% |
| 2018 FY | 17.2 Billion JPY | -21.0% |
| 2018 Q2 | 13.99 Billion JPY | -7.42% |
| 2018 Q1 | 15.11 Billion JPY | -30.6% |
| 2018 Q4 | 17.2 Billion JPY | 1.97% |
| 2018 Q3 | 16.86 Billion JPY | 20.57% |
| 2017 Q4 | 21.77 Billion JPY | 25.46% |
| 2017 FY | 21.77 Billion JPY | -18.35% |
| 2017 Q3 | 17.35 Billion JPY | -6.07% |
| 2017 Q2 | 18.47 Billion JPY | -6.73% |
| 2017 Q1 | 19.81 Billion JPY | -25.72% |
| 2016 Q1 | 11.18 Billion JPY | -34.68% |
| 2016 FY | 26.66 Billion JPY | 55.69% |
| 2016 Q4 | 26.66 Billion JPY | 12.23% |
| 2016 Q3 | 23.76 Billion JPY | -0.73% |
| 2016 Q2 | 23.93 Billion JPY | 113.93% |
| 2015 Q2 | 6.68 Billion JPY | -9.08% |
| 2015 Q3 | 11.1 Billion JPY | 66.15% |
| 2015 Q4 | 17.12 Billion JPY | 54.19% |
| 2015 FY | 17.12 Billion JPY | 158.08% |
| 2015 Q1 | 7.35 Billion JPY | 10.8% |
| 2014 Q2 | 3.54 Billion JPY | 307.59% |
| 2014 Q3 | 3.06 Billion JPY | -13.52% |
| 2014 FY | 6.63 Billion JPY | 81.04% |
| 2014 Q1 | 869 Million JPY | -76.3% |
| 2014 Q4 | 6.63 Billion JPY | 116.68% |
| 2013 Q4 | 3.66 Billion JPY | 141.03% |
| 2013 Q2 | 1.95 Billion JPY | -18.56% |
| 2013 FY | 3.66 Billion JPY | -30.04% |
| 2013 Q1 | 2.4 Billion JPY | -54.14% |
| 2013 Q3 | 1.52 Billion JPY | -22.28% |
| 2012 FY | 5.24 Billion JPY | -26.37% |
| 2012 Q3 | 3.46 Billion JPY | -13.18% |
| 2012 Q2 | 3.99 Billion JPY | -11.84% |
| 2012 Q4 | 5.24 Billion JPY | 51.23% |
| 2012 Q1 | 4.52 Billion JPY | -36.39% |
| 2011 Q2 | 6.53 Billion JPY | -12.38% |
| 2011 FY | 7.11 Billion JPY | -27.77% |
| 2011 Q4 | 7.11 Billion JPY | 21.53% |
| 2011 Q3 | 5.85 Billion JPY | -10.36% |
| 2011 Q1 | 7.45 Billion JPY | -24.33% |
| 2010 Q3 | 8.87 Billion JPY | 0.0% |
| 2010 FY | 9.85 Billion JPY | -2.0% |
| 2010 Q4 | 9.85 Billion JPY | 11.04% |
| 2009 Q3 | 9.7 Billion JPY | 9.39% |
| 2009 FY | 10.05 Billion JPY | 19.61% |
| 2009 Q2 | 8.86 Billion JPY | 0.0% |
| 2009 Q4 | 10.05 Billion JPY | 3.64% |
| 2008 FY | 8.4 Billion JPY | 15.96% |
| 2007 FY | 7.24 Billion JPY | 56.87% |
| 2006 FY | 4.62 Billion JPY | -30.76% |
| 2005 FY | 6.67 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 415.78 Thousand USD | -8192296.125% |
| Allstar Health Brands, Inc. | 2.21 Million USD | -1541012.779% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 16.87 Million USD | -201742.638% |
| Café Serendipity Holdings, Inc. | 412.56 Thousand USD | -8256275.95% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 272.02 Thousand USD | -12521772.748% |
| HealthWarehouse.com, Inc. | 2.73 Million USD | -1243112.842% |
| LIGAND PHARMACEUTICAL INC | 6.16 Million USD | -552422.303% |
| MedGen, Inc. | 24.47 USD | -139203105743.89% |
| Omni Health, Inc. | 1.84 Million USD | -1849897.23% |
| Oxford Investments Holdings Inc. | 207.06 Thousand USD | -16450289.974% |
| Pineapple, Inc. | 8.1 Million USD | -419938.123% |
| ScripsAmerica, Inc. | 1.2 Million USD | -2831858.909% |